Cart summary

You have no items in your shopping cart.

LGB321

SKU: orb2646033

Description

LGB321 is a potent and selective PIM2 kinase inhibitor that suppresses the proliferation of PIM2-dependent multiple myeloma cells. It effectively inhibits key oncogenic pathways, including mTORC1 signaling and BAD phosphorylation, making it a valuable tool for in vitro and in vivo studies of hematological malignancies.

Research Area

Signal Transduction

Images & Validation

Key Properties

CAS Number1210417-75-6
MW457.45
FormulaC23H22F3N5O2
SMILESN(C(=O)C=1N=C(C(F)=CC1)C2=C(F)C=CC=C2F)C=3C(=CC=NC3)N4C[C@H](C)[C@@H](O)[C@H](N)C4
TargetmTOR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • LGB321 monohydrochloride [orb3133423]

    1469925-36-7

    493.91

    C23H23ClF3N5O2

    10 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

LGB321 (orb2646033)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%